The Impact of Nursing Interventions on the Treatment Outcomes of Renal Cell Carcinoma with Postoperative Interleukin-2 and Recombinant Human Interferon

Figures & data

Table 1 The Demographic and Characteristics of Two Study Groups

Group	Male/Female n	Average Age	Left/Right Renal Cell Carcinoma	Average Disease Duration
Control group	43 (23/20)	50.5±7.3	21/24	1.8±5.1
Intervention group	47 (24/23)	51.2±6.8	25/20	1.9±5.5
p		0.24>0.05	–	0.28>0.05

Table 2 Comparison of Clinical Symptom Improvement Between Two Groups ()

Group	n	Duration of Fever Reduction (d)	Time for White Blood Cell Count to Normalize (d)	Hospital Stay (d)
Control group	43	3.2±0.5	6.5±1.5	26.1±2.5
Intervention group	47	2.4±0.3	5.1±1.2	21.1±2.1
t		4.825	4.126	5.667
p		0.031	0.041	0.001

Table 3 Comparison of Treatment and Nursing Outcomes Between Two Groups (N%)

Group	n	Complete Resolution	Partial Resolution	Improvement	Stable	Deterioration	p
Control group	43	24	16	2	4	0	0.154
Intervention group	47	26	15	2	4	0

Table 4 Adverse Reactions After Surgery Between Two Groups

Group	n	Fever	Gastrointestinal Symptoms	Bone Marrow Suppression	Neurological Abnormalities	p
Control group	43	3	2	4	1	0.036
Intervention group	47	1	0	2	0